Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Differential diagnosis of optic neuritis (review].
An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
Retinal Nerve Fiber Layer Thickness, Brain Atrophy, and Disability in Multiple Sclerosis Patients.
Factors affecting bone mineral density in multiple sclerosis patients.
We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?
Multiple sclerosis.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis.
Vitamin D, steroid hormones, and autoimmunity.
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments.
Association of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism With Multiple Sclerosis in Turkish Patients.
Management of Multiple Sclerosis in the Breastfeeding Mother.
Recurrent paraparesis and death of a patient with 'whippet' abuse.
Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis.
Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection.
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Long-Term Effects of Repeated Cycles of Intrathecal Triamcinolone Acetonide on Spasticity in MS Patients.
Orthopaedic Management of Spasticity.
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.
MAL Overexpression Leads to Disturbed Expression of Genes That Influence Cytoskeletal Organization and Differentiation of Schwann Cells.
Hyperinsulinemia in newly diagnosed patients with multiple sclerosis.
Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis
Transient oscillatory dynamics of interferon beta signaling in macrophages.

Pages